Hyperbaric oxygen therapy across acute and post-acute phases after out-of-hospital cardiac arrest: a multi-cohort randomized controlled pilot study (HOT-RESUS 1)
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Hyperbaric oxygen therapy (HBOT) after out-of-hospital cardiac arrest (OHCA) remains untested in humans despite promising preclinical evidence. We thus evaluated feasibility, tolerability, observed treatment-related adverse events, and early biological signals of HBOT across three distinct clinical cohorts and exposure subgroups. This prospective, single-centre, randomized, controlled, open-label pilot study enrolled (i) Intensive Care Unit (ICU) patients with sustained return of spontaneous circulation (ROSC) within the preceding 24 h, (ii) long-term OHCA survivors, and (iii) healthy volunteers. Within each cohort, participants were randomized to no HBOT, one HBOT session, or five HBOT sessions. Assessments included serial laboratory biomarkers, vascular function, neurocognitive testing, and patient-reported outcomes. Analyses were primarily descriptive, with additional between-group comparisons considered exploratory. The prespecified recruitment target was achieved (45/45 participants), all assigned HBOT sessions were completed (90/90; 100%), and all scheduled blood samples were obtained. No HBOT-related adverse events occurred. In ICU patients, serial biomarkers demonstrated pronounced temporal changes during the acute post-cardiac-arrest phase across inflammatory, oxidative stress, endothelial dysfunction, neuronal injury, and myocardial injury domains, whereas direct comparison of trajectories between HBOT groups were generally inconclusive. In long-term OHCA survivors and healthy volunteers, exploratory analyses suggested reductions in arterial stiffness and, particularly among survivors, favourable changes in neurocognitive and patient-reported outcomes, with several favourable numerical patterns observed in HBOT-exposed groups. Given the small subgroup sizes, extensive multiplicity, and generally inconclusive direct between-group comparisons, these findings remain exploratory. HOT-RESUS 1 demonstrated that the prespecified recruitment and HBOT procedures could be completed as planned, including treatment of selected acute post-ROSC ICU patients in a specialised hyperbaric centre, with no HBOT-related adverse events observed. Exploratory analyses showed dynamics of inflammatory and oxidative stress markers, arterial stiffness, and neurocognitive and patient-reported outcomes, with several favourable numerical patterns observed in HBOT-exposed groups. Although the small pilot sample, extensive multiplicity, and largely inconclusive direct between-group comparisons preclude attribution of these changes to HBOT or conclusions regarding biological or clinical efficacy, the findings identify possible biological and functional outcomes for further investigation in adequately powered randomized trials.
Source: Scientific Reports
Authors: Sebastian Schnaubelt, Erwin Snijders, Carlo Strouven, Eva Janssens, Philip Verdonck, Julie Lateur, Margot Peeters, Gaelle Vermeersch, Rudi De Paep, Johan Saenen, Annemiek Snoeckx, Patrick Sulzgruber, Catherine De Maeyer, Oliver Schlager, Philippe G. Jorens, Koenraad G. Monsieurs
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Keywords: hyperbaric oxygen therapy, out-of-hospital cardiac arrest, post-cardiac arrest syndrome, return of spontaneous circulation, endothelial dysfunction, oxidative stress, systemic inflammation, arterial stiffness, neurocognitive recovery, neuroinflammation, myocardial injury, treatment safety and feasibility, dose-response relationship
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W4416753116
